Metformin limits cerebral cavernous malformation development by targeting KLF4-mediated mitochondrial damage.
Yan C, Ye Y, Liu N, Zhang D, Du W, Li Y, Li G, Li C, Li J, Ma S, Dai Z, Xiong Z, Wang Y, Men C, Bi R, Duan Q, Xu W, Husilengtu, Cao Y, Du J, Shi C.
Yan C, et al.
Biochem Biophys Res Commun. 2025 Jun 24;777:152241. doi: 10.1016/j.bbrc.2025.152241. Online ahead of print.
Biochem Biophys Res Commun. 2025.
PMID: 40570636